BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 10611839)

  • 1. Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.
    Baker DA; Ferris DG; Martens MG; Fife KH; Tyring SK; Edwards L; Nelson A; Ault K; Trofatter KF; Liu T; Levy S; Wu J
    Infect Dis Obstet Gynecol; 2011; 2011():806105. PubMed ID: 21876641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant perianal condylomata acuminatum in a toddler treated with topical imiquimod alone.
    Kurihara Y; Sanmoto Y
    Pediatr Int; 2023; 65(1):e15670. PubMed ID: 37888539
    [No Abstract]   [Full Text] [Related]  

  • 3. Imiquimod 5% cream: a topical immune response modifier.
    Marini M
    Int J Dermatol; 2002 May; 41 Suppl 1():1-2. PubMed ID: 12087812
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of adenopathy during the use of topical imiquimod.
    Anadkat MJ; Bogucki BA
    J Am Acad Dermatol; 2011 May; 64(5):e75-7. PubMed ID: 21496688
    [No Abstract]   [Full Text] [Related]  

  • 5. Imiquimod for genital warts.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):118-9. PubMed ID: 9422045
    [No Abstract]   [Full Text] [Related]  

  • 6. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.
    Rosenblatt A; de Campos Guidi HG
    Int J STD AIDS; 2012 Dec; 23(12):909-10. PubMed ID: 23258837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imiquimod creme 5 per cent--a new agent for topical treatment of external condylomata].
    Petersen CS; Veien NK
    Ugeskr Laeger; 1999 Nov; 161(46):6368-70. PubMed ID: 10611839
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical imiquimod.
    Pearson GW; Langley RG
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D; vander Straten M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological and clinical profile of imiquimod (BESELNA CREAM 5%)].
    Tsuda T; Imada K; Mizuguchi K
    Nihon Yakurigaku Zasshi; 2008 Jul; 132(1):55-63. PubMed ID: 18622104
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of imiquimod 5% cream for the treatment of various dermatological conditions.
    Salasche S; Shumack S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():1-3. PubMed ID: 14616801
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.